Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 5, 2021
Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial diseaseWilliam A E Parker, Diana A Gorog, Tobias Geisler, et al.
Thrombosis and Haemostasis|July 29, 2010
Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitorsNikolaus Sarafoff, Dirk Sibbing, Ulrich Sonntag, et al.
Journal of the American College of Cardiology|November 14, 2015
Reply: Duration of Triple Therapy: A Clinical Question Yet to Be AnsweredNikolaus Sarafoff, Robert A Byrne, Julinda Mehilli, et al.
American Heart Journal|August 10, 2010
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stentsStefanie Schulz, Dirk Sibbing, Sigmund Braun, et al.
Kardiologia Polska|September 15, 2015
Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773)Łukasz Kołtowski, Daniel Aradi, Zenon Huczek, et al.
Thrombosis and Haemostasis|January 12, 2010
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stentingDirk Sibbing, Tanja Morath, Siegmund Braun, et al.
Journal of the American College of Cardiology|August 29, 2015
Reply: Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent ImplantationNikolaus Sarafoff, Robert A Byrne, Julinda Mehilli, et al.
Journal of the American College of Cardiology|February 16, 2010
A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatmentDirk Sibbing, Julia Stegherr, Siegmund Braun, et al.
Thrombosis and Haemostasis|April 8, 2009
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrelDirk Sibbing, Tanja Morath, Julia Stegherr, et al.
Journal of the American College of Cardiology|November 15, 2008
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarctionMelchior Seyfarth, Dirk Sibbing, Iris Bauer, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 5, 2021
Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial diseaseWilliam A E Parker, Diana A Gorog, Tobias Geisler, et al.
Thrombosis and Haemostasis|July 29, 2010
Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitorsNikolaus Sarafoff, Dirk Sibbing, Ulrich Sonntag, et al.
Journal of the American College of Cardiology|November 14, 2015
Reply: Duration of Triple Therapy: A Clinical Question Yet to Be AnsweredNikolaus Sarafoff, Robert A Byrne, Julinda Mehilli, et al.
American Heart Journal|August 10, 2010
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stentsStefanie Schulz, Dirk Sibbing, Sigmund Braun, et al.
Kardiologia Polska|September 15, 2015
Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773)Łukasz Kołtowski, Daniel Aradi, Zenon Huczek, et al.
Thrombosis and Haemostasis|January 12, 2010
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stentingDirk Sibbing, Tanja Morath, Siegmund Braun, et al.
Journal of the American College of Cardiology|August 29, 2015
Reply: Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent ImplantationNikolaus Sarafoff, Robert A Byrne, Julinda Mehilli, et al.
Journal of the American College of Cardiology|February 16, 2010
A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatmentDirk Sibbing, Julia Stegherr, Siegmund Braun, et al.
Thrombosis and Haemostasis|April 8, 2009
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrelDirk Sibbing, Tanja Morath, Julia Stegherr, et al.
Journal of the American College of Cardiology|November 15, 2008
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarctionMelchior Seyfarth, Dirk Sibbing, Iris Bauer, et al.
Pageof 20